XYL Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.3B
+9.9%
2.1B
-11.3%
2.4B
+5.7%
2.3B
-1.4%
2.3B
Cost of Revenue
1.4B
+3.9%
1.3B
-9.8%
1.5B
+5.8%
1.4B
-1.7%
1.4B
Gross Profit
963.0M
+19.9%
803.0M
-13.8%
932.0M
+5.5%
883.0M
-1.0%
892.0M
Operating Expenses
573.0M
+2.5%
559.0M
-3.5%
579.0M
+5.5%
549.0M
-6.5%
587.0M
R&D
59.0M
+5.4%
56.0M
-6.7%
60.0M
+15.4%
52.0M
-10.3%
58.0M
SG&A
503.0M
+6.6%
472.0M
-2.9%
486.0M
+2.5%
474.0M
-5.8%
503.0M
Operating Income
390.0M
+59.8%
244.0M
-30.9%
353.0M
+5.7%
334.0M
+9.5%
305.0M
EBITDA
541.0M
+30.4%
415.0M
-21.6%
529.0M
+6.0%
499.0M
+4.8%
476.0M
Net Income
261.0M
+38.1%
189.0M
-43.2%
333.0M
+47.3%
226.0M
+0.9%
224.0M
EPS (Basic)
$1.11
+40.5%
$0.79
-42.8%
$1.38
+48.4%
$0.93
+0.0%
$0.93
EPS (Diluted)
$1.11
+40.5%
$0.79
-42.3%
$1.37
+47.3%
$0.93
+0.0%
$0.93
Shares (Diluted)
236.6M
-2.8%
243.4M
-0.4%
244.2M
+0.1%
244.1M
+0.1%
243.9M
Xylem (XYL) โ€” Financials